Physician profile
Elliot Busch
NPI 1578903555
$30,108.86
in general payments reported to CMS, 2019-2025
34 companies · $721 in 2025
The $721 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,987 · 2020: $839 · 2021: $3,533 · 2022: $5,944 · 2023: $11K · 2024: $2,314 · 2025: $721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $10K · Food and Beverage: $3,677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,129.59 |
| Food and Beverage | $3,676.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $13,119.18 | 2019-2025 | Prostep, Prophecy, Ortholoc 2 Lapifuse |
| Medical Device Business Services, INC. | $4,432.18 | 2019 | |
| Paragon 28, INC. | $1,619.51 | 2022-2023 | Apex 3d |
| Mirus, LLC | $1,614.83 | 2024 | Atlas Plating System |
| Medline Industries Lp | $1,333.81 | 2022 | |
| Organogenesis INC. | $1,050.09 | 2019-2022 | |
| Linvatec Corporation | $1,014.50 | 2023 | Colink Plating System |
| Arthrex, INC. | $1,001.30 | 2023 | |
| In2bones USA, LLC | $968.62 | 2022 | |
| Horizon Therapeutics Plc | $924.30 | 2019-2022 | |
| Kci USA, INC. | $528.95 | 2019-2022 | |
| Smith+Nephew, INC. | $375.68 | 2019-2024 | Renasys Touch |
| Novus Surgical Solutions LLC | $345.63 | 2021-2022 | |
| Novus Surgical Consultants | $332.80 | 2023-2024 | |
| Musculoskeletal Transplant Foundation INC. | $280.78 | 2019-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $153.23 | 2019 | |
| Sanara Medtech INC. | $138.99 | 2023 | Celleraterx |
| Treace Medical Concepts, INC. | $134.05 | 2019-2025 | |
| Grt US Holding, INC. | $124.73 | 2021-2022 | |
| Forma Medical | $112.74 | 2024 | Optimalakin |
| Globus Medical, INC. | $111.51 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $81.21 | 2021-2022 | |
| Bioventus LLC | $53.98 | 2019-2021 | |
| Wright Medical Technology, INC. | $45.00 | 2020 | |
| Integra Lifesciences Corporation | $43.32 | 2019 | |
| Melinta Therapeutics, LLC | $32.68 | 2019 | |
| Alexion Pharmaceuticals, INC. | $27.69 | 2019 | |
| Nevro Corp. | $24.93 | 2019 | |
| Osiris Therapeutics INC. | $19.28 | 2019 | |
| Kuros Biosciences USA, INC | $18.91 | 2025 | Magnetos |
| Assertio Therapeutics, INC. | $15.19 | 2020 | |
| Synergy Orthopedics, LLC | $11.95 | 2022 | |
| Ermi LLC | $10.34 | 2020 | |
| Orthofix Medical, INC. | $6.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elliot Busch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.